Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site
- PMID: 2543441
- DOI: 10.1021/bi00432a005
Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site
Abstract
Specific cell surface receptors for plasminogen (Pg) are expressed by a wide variety of cell types and serve to promote fibrinolysis and local Pg proteolysis. Pg types 1 and 2, separated by chromatography on concanavalin A-Sepharose, were utilized to determine their binding to the monocytoid U937 cell line. Both forms bind in a dose-dependent manner. However, Pg 2 binds to the cellular receptor considerably better than Pg 1 and at equilibrium demonstrates approximately 10-fold greater binding. Lipoprotein a [Lp(a)], which possesses a subunit showing considerable homology to Pg, competes with Pg 2 for the Pg receptor in U937 cells. Moreover, Pg 1 is not able to displace Pg 2 from the receptor. These studies suggest that high levels of Lp(a) may alter the profibrinolytic activity at the cell surface and increase the risks of atherosclerosis and thrombosis. This hypothesis is in accord with the 2-5-fold increased risk of atherosclerosis in patients having high levels of Lp(a).
Similar articles
-
Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding.Arch Biochem Biophys. 1991 May 1;286(2):625-8. doi: 10.1016/0003-9861(91)90090-6. Arch Biochem Biophys. 1991. PMID: 1654795
-
A potential basis for the thrombotic risks associated with lipoprotein(a).Nature. 1989 May 25;339(6222):301-3. doi: 10.1038/339301a0. Nature. 1989. PMID: 2542796
-
Discriminating between cell surface and intracellular plasminogen-binding proteins: heterogeneity in profibrinolytic plasminogen-binding proteins on monocytoid cells.Thromb Haemost. 2000 Nov;84(5):882-90. Thromb Haemost. 2000. PMID: 11127872
-
Lp(a): an interloper into the fibrinolytic system?Thromb Haemost. 1990 Jun 28;63(3):331-5. Thromb Haemost. 1990. PMID: 2169655 Review. No abstract available.
-
Lipoprotein (a) in the regulation of fibrinolysis.J Atheroscler Thromb. 1995;2 Suppl 1:S5-7. doi: 10.5551/jat1994.2.supplement1_s5. J Atheroscler Thromb. 1995. PMID: 9225222 Review.
Cited by
-
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ. 1990 Dec 1;301(6763):1248-51. doi: 10.1136/bmj.301.6763.1248. BMJ. 1990. PMID: 2148699 Free PMC article. Clinical Trial.
-
N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.Glycoconj J. 2016 Jun;33(3):359-76. doi: 10.1007/s10719-015-9641-3. Epub 2015 Dec 5. Glycoconj J. 2016. PMID: 26638212 Review.
-
Hypothesis: lipoprotein(a) is a surrogate for ascorbate.Proc Natl Acad Sci U S A. 1990 Aug;87(16):6204-7. doi: 10.1073/pnas.87.16.6204. Proc Natl Acad Sci U S A. 1990. PMID: 2143582 Free PMC article.
-
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10193-7. doi: 10.1073/pnas.89.21.10193. Proc Natl Acad Sci U S A. 1992. PMID: 1438209 Free PMC article.
-
Effect of desialylation on the biological properties of human plasminogen.Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):81-6. doi: 10.1042/bj2840081. Biochem J. 1992. PMID: 1599413 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous